Clinical Trials for Bladder Cancer

Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors

NCT ID: NCT03740256

This clinical trial is studying a new treatment approach for patients with advanced cancers that are positive for a protein called HER2. The trial combines two experimental treatments: special immu...

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

NCT ID: NCT03520491

This clinical trial is looking at the safety of a type of cancer treatment called immunotherapy, specifically using two drugs, nivolumab and ipilimumab, in patients with bladder cancer who cannot r...

Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery

NCT ID: NCT06926374

This clinical trial is studying a new robotic surgical system called the Sentire Robotic Surgical System, which is designed to help perform major surgeries for conditions like colorectal cancer, pr...

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

NCT ID: NCT06904365

This clinical trial is looking at a new way to protect the ovaries of young women who need radiation therapy for certain cancers, such as uterine or rectal cancer. Many women under 50 are facing th...

Bladder Cancer Screening Trial

NCT ID: NCT05646485

The Bladder Cancer Screening Trial is studying whether regular urine tests can help detect bladder cancer earlier in people who are at higher risk. Researchers want to find out if testing urine eve...

A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

NCT ID: NCT06331299

This clinical trial is studying a new treatment called UGN-103 for patients with low-grade non-muscle invasive bladder cancer. The goal is to see how effective and safe this treatment is when it is...

Integrated Actionable Aging Assessment for Cancer Patients Pilot

NCT ID: NCT05871008

This clinical trial, called the Integrated Actionable Aging Assessment for Cancer Patients Pilot (IA3-CP), is focused on improving care for older adults with various types of cancer, including brea...

Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)

NCT ID: NCT06721260

The METRICS trial is a research study focused on understanding the energy needs and muscle function of patients undergoing treatment for bladder cancer. This study aims to gather important informat...

IDOV-Immune for Advanced Solid Tumors

NCT ID: NCT06910657

This clinical trial is studying a new treatment called IDOV-Immune for adults with advanced solid tumors, such as colorectal, pancreatic, and breast cancers, that have not improved with standard th...

Trop2-targeted immunoPET Imaging of Solid Tumors

NCT ID: NCT06851663

This clinical trial is studying a new imaging technique called Trop2-targeted immunoPET/CT, which aims to help doctors better see and diagnose solid tumors like bladder cancer, prostate cancer, and...

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

NCT ID: NCT06470282

This clinical trial is studying a new treatment for muscle-invasive bladder cancer, specifically looking at how well a combination of two drugs, enfortumab vedotin and pembrolizumab, works when giv...

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

NCT ID: NCT04157985

This clinical trial is studying the best length of treatment with a type of cancer therapy called PD-1/PD-L1 inhibitors, which are used for various advanced solid tumors, including lung, bladder, a...

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT ID: NCT06022029

This clinical trial is studying a new treatment called ONM-501, which can be given alone or combined with another medication called cemiplimab, for patients with advanced solid tumors and lymphomas...

A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer

NCT ID: NCT06735287

This clinical trial is investigating new treatment options for patients with large non-muscle-invasive bladder cancer (NMIBC), specifically tumors that are 5 cm or larger. The goal is to find a way...

Naptumomab Estafenatox in Combination with Durvalumab in Subjects with Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT ID: NCT03983954

This clinical trial is investigating a new treatment approach for patients with advanced or metastatic solid tumors, including types of cancer such as breast, ovarian, pancreatic, and esophageal ca...

The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging

NCT ID: NCT06763354

This clinical trial is studying a new imaging method for bladder tumors using a special injection called gallium [68Ga] NOTA-DNA multivalent SGC8. The goal is to see how well this injection can hel...

Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool

NCT ID: NCT06878027

This clinical trial is investigating how urine tests can help detect bladder cancer early. The researchers are looking at specific changes in the DNA found in urine, known as methylation patterns, ...

Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids

NCT ID: NCT05024734

This clinical trial is studying a new way to treat patients with non-muscle invasive bladder cancer, specifically for those at intermediate risk. Researchers will collect tumor samples from patient...

The Use of Remote Monitoring to Improve Patient-Reported Outcomes and Readmission Rates Following Radical Cystectomy

NCT ID: NCT06397040

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

NCT ID: NCT06488222

This clinical trial is studying a new treatment approach for patients with low-grade intermediate risk bladder cancer, specifically looking at the effectiveness of two medications, gemcitabine and ...